BAP/Psychiatry Consortium Drug Discovery Session
Monday, 27th July 2020
The aim of this Psychopharmacology Drug Discovery session is to discover the evolving world of CNS drug discovery. This innovative session will showcase the new approach of academic and biotech groups towards target validation, drug discovery and development in neuroscience. Speakers will explain the different approaches taken by these groups and how these differ from the traditional approach taken by Pharma. The first part will be pre-clinically focussed with the second part moving on to later stage programs with products in clinical development.
The joint BAP / PC Drug Discovery Session, which was held on 22nd July 2020 via Zoom, is now available to view online: